ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,691Medicare Part D Prescriptions Filled, Including Refills

Rank: 23 out of 247

$519K Total Retail Price of All Prescriptions

Rank: 37 out of 247

409 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 409 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 409 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

3% of this provider’s 7,106 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
OMEPRAZOLE 351 295 1 4
SIMVASTATIN 305 284 2 1
LISINOPRIL 304 272 3 2
METOPROLOL TARTRATE 265 255 4 7
LEVOTHYROXINE SODIUM 226 183 5 3
ATENOLOL 218 177 6 10
AMLODIPINE BESYLATE 215 196 7 6
FUROSEMIDE 202 163 8 5
HYDROCHLOROTHIAZIDE 191 174 9 9
SERTRALINE HCL 174 136 10 16
PANTOPRAZOLE SODIUM 173 149 11 19
HYDROCODONE-ACETAMINOPHEN 172 150 S3 12 11
GLYBURIDE 141 107 R 13 41
METOPROLOL SUCCINATE 136 112 14 14
WARFARIN SODIUM 134 129 15 13
CITALOPRAM HBR 134 117 15 20
GABAPENTIN 129 121 17 17
ZOLPIDEM TARTRATE 101 79 18 24
ATORVASTATIN CALCIUM 86 60 19 8
LOSARTAN POTASSIUM 84 76 20 15
OXYCODONE HCL 82 38 S2 21 27
ALENDRONATE SODIUM 82 82 21 32
PREDNISONE 80 71 23 21
PRAVASTATIN SODIUM 78 70 24 23
RANITIDINE HCL 76 38 25 34
PROAIR HFA 73 54 26 29
FENTANYL 70 47 S2 27 72
CYCLOBENZAPRINE HCL 69 37 R 28 54
ADVAIR DISKUS 69 35 28 18
TRAMADOL HCL 68 65 30 25
METFORMIN HCL ER 68 53 30 82
CYMBALTA 65 35 32 52
POTASSIUM CHLORIDE 63 56 33 36
ALLOPURINOL 63 55 33 33
AZITHROMYCIN 63 51 33 48
LANSOPRAZOLE 60 49 36 166
FLUTICASONE PROPIONATE 59 41 37 37
GLIPIZIDE 59 59 37 43
POLYETHYLENE GLYCOL 3350 59 53 37 77
MELOXICAM 57 51 40 70
METFORMIN HCL 55 40 41 12
PAROXETINE HCL 53 51 42 45
CIPROFLOXACIN HCL 53 47 42 89
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 51 42 51
LOVASTATIN 52 48 45 22
DONEPEZIL HCL 51 51 46 35
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 12, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.